Cost-utility and budget impact analyses of gefitinib in second-line treatment for advanced non-small cell lung cancer from Thai payer perspective
Aim: To evaluate the cost utility and budget impact of second-line gefitinib for non-small cell lung cancer from a Thai payer perspective. Methods: A Markov model with three health states (pre-progression, post-progression and death) was constructed to estimate direct medical costs and outcomes comp...
Saved in:
| Main Authors: | , , |
|---|---|
| 格式: | Article |
| 出版: |
Wiley-Blackwell
2015
|
| 主題: | |
| 在線閱讀: | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84857528545&origin=inward http://cmuir.cmu.ac.th/handle/6653943832/38524 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|